antibiotic treatment
OtherAntibiotic treatment
NCT Number: NCT04681339
A study to observe how often antibiotics are prescribed in children hospitalized for pneumonia and how doctors decide if a child needs antibiotics or not. Parent satisfaction will also be recorded.
Interested in participating?
Request Info3 month–18 year
All sexes
Observational
Die Filderklinik, Filderstadt, Baden-Wurttemberg, Germany
An observational study to document the antibiotic treatment rate of children hospitalized for community acquired pneumonia at a pediatric department with longstanding practice of restrictive antibiotic prescribing. Patients will be enrolled consecutively and treated according to in-house standard operating procedure. Antibiotic treatment rate, severity of disease and medical complication rate in antibiotic and non-antibiotic managed children, frequency of predefined factors in physician decision making on antibiotic use, and parental satisfaction will be recorded. Parents will be contacted at least 4 weeks after discharge to inquire about recurrence or readmission.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Antibiotic treatment
No antibiotic treatment
Time frame: During hospitalization, an average of 7 days
Rates of treatment with and without antibiotics during hospitalization
Time frame: During hospitalization, an average of 7 days
Medical complications defined as a) admission to intensive care, mechanical ventilation, transfer to tertiary car center OR b) pleural effusion or empyema, pneumothorax, lung abscess, bronchopleural fistula, necrotizing pneumonia, acute respiratory failure, infectious complication (meningitis, septic shock).
Time frame: During hospitalization, an average of 7 days
Physician questionnaire (closed-ended questions)
Time frame: At discharge, assessing the entire duration of the hospital stay, an average of 7 days
Parental satisfaction questionnaire (closed-ended questions)
Time frame: At discharge, assessing the entire duration of the hospital stay, an average of 7 days
Number of hospitalization days
Time frame: During hospitalization, an average of 7 days
Co-morbidities that may affect decision on antimicrobial use: a) chronic conditions (e.g. neurological conditions such as cerebral palsy, Down syndrome; or chronic respiratory conditions such as asthma, cystic fibrosis; or heart conditions). b) acute infectious comorbidities: bronchiolitis, otitis media, urinary tract infection, confirmed influenza virus or Respiratory Syncytial Virus or SARS-CoV2.
Time frame: During hospitalization, an average of 7 days
Oxygen therapy for O2 saturation <92%
Time frame: During hospitalization, an average of 7 days
Number of doses of paracetamol or ibuprofen during hospitalization
Time frame: During hospitalization, an average of 7 days
Number of complementary medication during hospitalization
Time frame: 4 weeks after end of hospitalization
New hospital admission for pneumonia; treatment requiring recurrence of pneumonia
Contact information is provided by the study sponsor or research team.
ARCIM Institute Academic Research in Complementary and Integrative Medicine
Other
Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia: a Prospective, Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06325293
Bacterial Infections, Bacterial Infections and Mycoses
Aarau, Canton of Aargau, Switzerland
View Trial DetailsNCT06494072
Community Acquired Pneumonia in Children, Community-Acquired Infections
Milwaukee, Wisconsin, United States
View Trial DetailsNCT05722938
Community-Acquired Infections, Community-Acquired Pneumonia
Mobile, Alabama, United States
View Trial DetailsNCT06601998
COVID-19, COVID-19 Pneumonia
Alexandroupoli, Greece
View Trial Details